Search
  • ryanjamesjessup

Imaging in Therapeutic Trials | Early Phase

Updated: Apr 28

Imaging in therapeutic trials is the key process in expanding the understanding, methodology and metrics which are required to make determinations in drug targeting and efficacy.


This spans most all imaging modalities, organ systems, and therapeutic areas.


“Trial design, data analysis, and expert image reads are our areas of expertise.” - Dr. J. James Frost, Owner of BioMolecular Imaging


Specifically, early phase imaging often examines the behavior of a new molecular agent that is a counterpart to a therapeutic drug and binds to the same target site.


Here at BioMolecular Imaging, we serve as your internal imaging expert and guide you through the entire development process from preclinical imaging data to protocol and IND preparation, to site selection and study execution. If necessary, we can identify, vet, and work with full-service CRO’s appropriate for your project or engage with university sites to tailor image acquisition and analysis protocols.


With regard to university interactions, the owner of BioMolecular Imaging, Dr. J. James Frost, a Professor at Johns Hopkins and at Yale, has deep experience with IRB’s, informed consent, radiation committees, budgeting, and faculty investigators and designed this company so that it can help you navigate the university environment and achieve rapid study approval and timely execution and analysis, while minimizing time and costs.


In conclusion, early phase studies with conventional imaging modalities typically examine safety and drug dosing which can be used for study entry criteria and to select subject subpopulations that will maximize subject homogeneity and enhance outcomes for key go/no-go decision-making.


About BioMolecular Imaging


BioMolecular Imaging (BMI Consultants) is a molecular imaging and clinical trial consultancy owned and operated by Dr. J. James Frost M.D./Ph.D out of Baltimore Maryland. BMI has been involved with clinical, therapeutic & diagnostic imaging focused on Oncology, Brain, Biomarkers, Cardiology and Central Image Interpretations for over 20 years.


To learn more about BioMolecular Imaging, please visit https://www.BioMolecularImaging.com or connect with:


SoundCloud - https://soundcloud.com/BioMolecular-Imaging

Facebook - https://www.facebook.com/BMIConsultants

Twitter - https://twitter.com/BMIConsultants

LinkedIn - https://www.linkedin.com/company/BioMolecular-Imaging

YouTube - https://www.youtube.com/channel/UCkdv6cOQ8HunygNTtU66s2w


Copyright © 2022 BioMolecular Imaging


BioMolecular Imaging is a registered trademark of BioMolecular Imaging D.B.A. BMI Consultants

11 views0 comments

Recent Posts

See All

Diagnostic imaging is a core competency of BioMolecular Imaging - and is the approach of imaging the human body to analyze and form medical intervention, especially when viewing the function of organs

Imaging in therapeutic trials is the key process in expanding the understanding, methodology and metrics which are required to make determinations in drug targeting and efficacy. This spans most all i

A very active area of current investigation and commercialization is molecular and functional biomarker development. These biomarkers can serve as surrogate endpoints for therapeutic efficacy and are